IRIS Accounts Production v24.3.0.553 08623058 Board of Directors 1.8.23 31.7.24 31.7.24 false true false false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh086230582023-07-31086230582024-07-31086230582023-08-012024-07-31086230582022-07-31086230582022-08-012023-07-31086230582023-07-3108623058ns15:EnglandWales2023-08-012024-07-3108623058ns14:PoundSterling2023-08-012024-07-3108623058ns10:Director12023-08-012024-07-3108623058ns10:PrivateLimitedCompanyLtd2023-08-012024-07-3108623058ns10:SmallEntities2023-08-012024-07-3108623058ns10:AuditExempt-NoAccountantsReport2023-08-012024-07-3108623058ns10:SmallCompaniesRegimeForDirectorsReport2023-08-012024-07-3108623058ns10:SmallCompaniesRegimeForAccounts2023-08-012024-07-3108623058ns10:FullAccounts2023-08-012024-07-310862305812023-08-012024-07-3108623058ns10:Director22023-08-012024-07-3108623058ns10:RegisteredOffice2023-08-012024-07-3108623058ns5:CurrentFinancialInstruments2024-07-3108623058ns5:CurrentFinancialInstruments2023-07-3108623058ns5:ShareCapital2024-07-3108623058ns5:ShareCapital2023-07-3108623058ns5:RetainedEarningsAccumulatedLosses2024-07-3108623058ns5:RetainedEarningsAccumulatedLosses2023-07-3108623058ns5:IntangibleAssetsOtherThanGoodwill2023-08-012024-07-3108623058ns5:PatentsTrademarksLicencesConcessionsSimilar2023-08-012024-07-3108623058ns5:IntangibleAssetsOtherThanGoodwill2023-07-3108623058ns5:IntangibleAssetsOtherThanGoodwill2024-07-3108623058ns5:IntangibleAssetsOtherThanGoodwill2023-07-3108623058ns5:PlantMachinery2023-07-3108623058ns5:PlantMachinery2023-08-012024-07-3108623058ns5:PlantMachinery2024-07-3108623058ns5:PlantMachinery2023-07-3108623058ns5:WithinOneYearns5:CurrentFinancialInstruments2024-07-3108623058ns5:WithinOneYearns5:CurrentFinancialInstruments2023-07-31
REGISTERED NUMBER: 08623058 (England and Wales)















Unaudited Financial Statements for the Year Ended 31 July 2024

for

SU Medical Limited

SU Medical Limited (Registered number: 08623058)






Contents of the Financial Statements
for the Year Ended 31 July 2024




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


SU Medical Limited

Company Information
for the Year Ended 31 July 2024







DIRECTORS: Dr Sang Ah Kim
Dr Jong Kim





REGISTERED OFFICE: 3A Evolution
Wynyard Business Park
Wynyard
Billingham
TS22 5TB





REGISTERED NUMBER: 08623058 (England and Wales)





ACCOUNTANTS: Flannagans - Hartlepool Office
Chartered Certified Accountants
7 Bankside
The Watermark
Gateshead
Tyne and Wear
NE11 9SY

SU Medical Limited (Registered number: 08623058)

Balance Sheet
31 July 2024

2024 2023
Notes £    £    £    £   
FIXED ASSETS
Intangible assets 4 117,027 117,027
Tangible assets 5 2,928 3,866
119,955 120,893

CURRENT ASSETS
Debtors 6 16,000 428,576
Cash at bank 101,453 74,611
117,453 503,187
CREDITORS
Amounts falling due within one year 7 33,189 60,623
NET CURRENT ASSETS 84,264 442,564
TOTAL ASSETS LESS CURRENT
LIABILITIES

204,219

563,457

CAPITAL AND RESERVES
Called up share capital 101 101
Retained earnings 204,118 563,356
204,219 563,457

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 July 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 July 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

SU Medical Limited (Registered number: 08623058)

Balance Sheet - continued
31 July 2024


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 19 November 2024 and were signed on its behalf by:





Dr Jong Kim - Director


SU Medical Limited (Registered number: 08623058)

Notes to the Financial Statements
for the Year Ended 31 July 2024

1. STATUTORY INFORMATION

SU Medical Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Patents and licences are being amortised evenly over their estimated useful life of nil years.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 3 (2023 - 2 ) .

SU Medical Limited (Registered number: 08623058)

Notes to the Financial Statements - continued
for the Year Ended 31 July 2024

4. INTANGIBLE FIXED ASSETS
Other
intangible
assets
£   
COST
At 1 August 2023
and 31 July 2024 117,027
NET BOOK VALUE
At 31 July 2024 117,027
At 31 July 2023 117,027

5. TANGIBLE FIXED ASSETS
Plant and
machinery
etc
£   
COST
At 1 August 2023 15,447
Additions 2,732
At 31 July 2024 18,179
DEPRECIATION
At 1 August 2023 11,581
Charge for year 3,670
At 31 July 2024 15,251
NET BOOK VALUE
At 31 July 2024 2,928
At 31 July 2023 3,866

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Trade debtors 16,000 24,000
Amounts owed by group undertakings - 398,000
Other debtors - 6,576
16,000 428,576

SU Medical Limited (Registered number: 08623058)

Notes to the Financial Statements - continued
for the Year Ended 31 July 2024

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Taxation and social security 23,831 33,602
Other creditors 9,358 27,021
33,189 60,623